Chemoinformaics analysis of 2,2,3-Trimethylhexane
| Molecular Weight | 128.259 | nRot | 2 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 0 |
| Exact Molecular Weight | 128.156 | nRing | 0 |
| Solubility: LogS | -5.043 | nHRing | 0 |
| Solubility: LogP | 4.82 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 28.3659 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.534 |
| Synth | 2.707 |
| Natural Product Likeliness | 0.417 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.102 |
| Pgp-sub | 0.001 |
| HIA | 0.011 |
| CACO-2 | -4.253 |
| MDCK | 0.0000169 |
| BBB | 0.855 |
| PPB | 0.950069 |
| VDSS | 2.175 |
| FU | 0.0926872 |
| CYP1A2-inh | 0.624 |
| CYP1A2-sub | 0.778 |
| CYP2c19-inh | 0.296 |
| CYP2c19-sub | 0.915 |
| CYP2c9-inh | 0.233 |
| CYP2c9-sub | 0.856 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.403 |
| CYP3a4-inh | 0.065 |
| CYP3a4-sub | 0.297 |
| CL | 8.938 |
| T12 | 0.264 |
| hERG | 0.014 |
| Ames | 0.003 |
| ROA | 0.058 |
| SkinSen | 0.245 |
| Carcinogencity | 0.033 |
| EI | 0.973 |
| Respiratory | 0.394 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.934314 |